Back to LYEL

GOLDMAN SACHS GROUP INC → LYEL

GOLDMAN SACHS GROUP INC LYEL Position History

Lyell Immunopharma, Inc. • Healthcare

Quarters held
6
Latest value
$116K
Q3 2026
Peak value
$3M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$3M
Q4 2025$3M
Q1 2026$2.3M
Q2 2026$1.2M
Q3 2026$947K
Q3 2026$116K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$116K11.9K——
Q3 2026$947K96.7K——
Q2 2026$1.2M86.8K——
Q1 2026$2.3M114.5K——
Q4 2025$3M96.7K——
Q4 2025$3M96.7K——

Other funds holding LYEL

Other GOLDMAN SACHS GROUP INC positions

NVDA

NVIDIA CORPORATION

$37B
AAPL

APPLE INC

$31.7B
NVDA

NVIDIA CORPORATION

$31.3B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.3B
AAPL

APPLE INC

$26.9B
NVDA

NVIDIA CORPORATION

$26.5B